Joining the patient on the path to customized prophylaxis: one hemophilia team explores the tools of engagement

  title={Joining the patient on the path to customized prophylaxis: one hemophilia team explores the tools of engagement},
  author={Deborah Gue and Sandra Squire and Kam A McIntosh and Claude Bartholomew and Nicole M. Summers and Haowei Linda Sun and Ming Yang and Shannon C. Jackson},
  journal={Journal of Multidisciplinary Healthcare},
  pages={527 - 534}
Background The relationship between hemophilia team interventions and achievement of optimal clinical outcomes remains to be elucidated. The British Columbia Hemophilia Adult Team has previously reported results of a comprehensive approach to individualize prophylaxis that has resulted in substantially reduced bleeding rates. In order to facilitate knowledge exchange and potential replication, it was important to gain a thorough understanding of the team’s approach. Methods A focus group of the… 

Figures and Tables from this paper

Health education and empowerment in adult patients with haemophilia
Patients with haemophilia are in general reasonably empowered on account of their personal experiences and their interaction with the healthcare providers, making it easier to step up educational interventions in patients at lower haemorrhagic risk.
Treatment adherence in hemophilia
Personalized strategies are needed to reinforce the importance of and encourage confidence in administering the regular infusions required for prophylactic therapy, and the advent of extended half-life clotting factors requiring less frequent infusion may improve adherence.
The role of patient and healthcare professionals in the era of new hemophilia treatments in developed and developing countries
The overall role of shared decision making in medicine is outlined, with special emphasis on models for practical implementation, and application to new therapeutics is discussed through a case-based approach.
Optimizing language for effective communication of gene therapy concepts with hemophilia patients: a qualitative study
A first-ever study of gene therapy lexicon was conducted using established methods of market research and linguistic analysis and found that the use of preferred language across different stakeholders increases understanding and comfort during discussions of novel and complex therapeutic modalities such as gene therapy.
Ageing and Increasing Doses are Factors Related to Delays for Adults with Haemophilia to Seek Prophylactic Clotting Factors
  • R. M. Camelo
  • Medicine
    American Journal of Biomedical Science & Research
  • 2021
Adherence to prophylaxis influences the effectiveness of the haemophilia treatment, and the interdisciplinary team should develop age-based strategies to ensure the patient will receive theProphylactic clotting factor at the scheduled time.
A clinical review of communication training for haematologists and haemato‐oncologists: a case of art versus science
The need for new interventions for haematologists which focus on producing and maintaining positive patient outcomes is highlighted, and five applicable interventions are identified.
Patient‐centred care in haemophilia: Patient perspectives on visualization and participation in decision‐making
This qualitative study explored how the British Columbia Adult Haemophilia Team recently adopted a patient‐centred care approach and how this approach changed patients’ understanding of haemophile and how it facilitated them to make treatment decisions.
Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.
This review includes suggestions around formulating treatment plans for patients with mild haemophilia, encompassing the full spectrum from clinical care of the newly diagnosed neonate to that of the ageing patient with multiple comorbidities.
Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continents
These cases of people with hemophilia (PWH) illustrate the importance of understanding the patient's expectations and desires and adapting treatment to meet these needs, in addition to traditional


A survey of adherence to haemophilia therapy in six European countries: results and recommendations
In this selected group of European haemophilia patients, adherence to treatment appears higher than for most patients with other chronic diseases, however, it remains important to be aware of the possibility of non‐adherence given the serious implications, particularly when considering a differentlyselected group of patients.
Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review
Determinants of adherence to prophylaxis were age, symptoms, beliefs, and the relation with the health care provider, which may provide a first step towards a strategy to promote adherence in haemophilia.
Effects of secondary prophylaxis started in adolescent and adult haemophiliacs
With respect to on‐demand treatment, higher factor consumption and cost of secondary prophylaxis were balanced by marked clinical benefits and greater well‐being in this cohort of adolescent/adult haemophiliacs.
Men, Masculinities, and Hemophilia
The inductively derived findings revealed bleed-related joint pain as the primary prompt for men to treat or seek medical help and masculine ideals act as important context in which men navigate hemophilia management practices and may facilitate contesting or conceding behaviors.
Guidelines for the management of hemophilia
These evidence‐based guidelines offer practical recommendations on the diagnosis and general management of hemophilia, as well as the management of complications including musculoskeletal issues, inhibitors, and transfusion‐transmitted infections.
Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators.
Although HIV infection and the presence of severe liver disease remain strong predictors of mortality, survival is significantly greater among hemophilics who receive medical care in HTCs, and those persons who had received care in an HTC had a significantly decreased risk of death.
Patterns of tertiary prophylaxis in Canadian adults with severe and moderately severe haemophilia B
  • S. Jackson, M. Yang, M. Poon
  • Medicine
    Haemophilia : the official journal of the World Federation of Hemophilia
  • 2014
This observational study was conducted to gain a better understanding of the recent Canadian experience with tertiary prophylaxis in adults with severe and moderately severe haemophilia B.
Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions
A significant number of older adults use secondary/tertiary continuous prophylaxis in Canada, accounting for a significant fraction of factor concentrate utilization.
Better adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophilia
Among AYA PWHs, better adherence to prescribed treatment regimen was associated with significantly lower odds of having high chronic pain, and non‐whites were >4 times as likely as whites to report high chronicPain.
Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia
Improved understanding of the effect of PK and dose frequency on factor levels in patients on prophylaxis will help tailor regimens to individuals better and allow more cost effective use of coagulation factor concentrates.